Bronchonib 100mg Capsule is a targeted therapy medication used in the treatment of certain types of non-small cell lung cancer (NSCLC). Its active ingredient is Afatinib, a tyrosine kinase inhibitor (TKI). Afatinib works by blocking the activity of specific proteins called epidermal growth factor receptors (EGFR) that are involved in the growth and spread of cancer cells. By inhibiting these receptors, Bronchonib helps to slow down or stop the growth of cancerous tumors.
Bronchonib 100mg Capsule is indicated for patients with metastatic NSCLC whose tumors have specific EGFR mutations. It is typically prescribed when other cancer treatments have not been effective or as a first-line treatment in certain cases. The dosage and duration of treatment are determined by a qualified healthcare professional based on the individual patient’s condition and response to therapy.
Common side effects may include diarrhea, rash, acne, stomatitis (mouth sores), and nail changes. Less common but serious side effects can occur, so it is important to discuss any concerns with your doctor. Bronchonib should be stored at room temperature, away from moisture and heat, and out of reach of children.
